Metagenomic Sequencing Market
Metagenomic Sequencing Market Size, Share & Trends Analysis Report byType (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental and Veterinary), by Product & Service (Reagents and Consumables, Instruments, Sequencing Services and Analysis and Data Interpretation Solutions), by Technology (16s Rna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly and Metatranscrigptomics) and by Workflow (Sample Preparation, Sequencing and Data Processing and Analysis)Forecast Period (2024-2031)
Metagenomic sequencing market is anticipated to grow at a considerable CAGR of 7.6% during the forecast period (2024-2031). Metagenomic sequencing involves the study of genetic material collected directly from environmental samples, such as soil, water, air, or biological specimens, without the need for isolating and culturing individual organisms. This approach enables researchers to analyze the genetic composition and diversity of entire microbial communities within these samples.
Market Dynamics
Technological Innovations in the Metagenomic Sequencing Market
Technological advancements play a crucial role in shaping the landscape of the global metagenomic sequencing market. Continuous innovation in sequencing technologies, bioinformatics tools, and data analysis methods has significantly improved the efficiency, accuracy, and cost-effectiveness of metagenomic sequencing processes. For instance, the development of next-generation sequencing (NGS) platforms has revolutionized the field by enabling high-throughput sequencing of microbial DNA directly from complex environmental samples. These advancements have expanded the scope of metagenomic sequencing applications, allowing researchers to study microbial communities in diverse environments with unprecedented depth and resolution. Additionally, ongoing research and development efforts aim to overcome existing challenges in metagenomic sequencing, such as reducing sequencing errors, enhancing data analysis algorithms, and improving sample preparation techniques. For instance, in June 2023, Delve Bio launched with $35M series A to advance its metagenomic sequencing platform for infectious disease diagnosis.
Elevating Healthcare Expenditure
The global rise in healthcare expenditure is another significant driver of the metagenomic sequencing market. Governments, healthcare providers, and research institutions globally are increasingly investing in innovative technologies and approaches to improve patient care, advance medical research, and address public health challenges. Metagenomic sequencing holds immense potential in healthcare applications, including infectious disease surveillance, clinical diagnostics, drug discovery, and personalized medicine. As a result, the growing recognition of the importance of the human microbiome in health and disease has led to increased funding and investment in metagenomic sequencing technologies and services.
Market Segmentation
Our in-depth analysis of the global metagenomic sequencing market includes the following segments by type, product& service, and technology and workflow:
- Based on type, the market is sub-segmented into drug discovery, clinical diagnostic, soil microbiome, industrial applications, ecological and environmental and veterinary.
- Based on product&service, the market is sub-segmented into reagents and consumables, instruments, sequencing services and analysis and data interpretation solutions.
- Based on technology, the market is sub-segmented into 16s rna sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly and metatranscriptomics.
- Based on workflow, the market is sub-segmented into sample preparation, sequencing and data processing and analysis.
16S RNASequencing is Projected to Emerge as the Largest Segment
Based on the technology, the global metagenomic sequencing market is sub-segmented 16s rna sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly and metatranscriptomics. Among these, the 16s rna sequencingsub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes the capability to provide insights into microbial community composition and diversity. Unlike whole-genome sequencing, which sequences the entire genome of an organism, 16S RNA sequencing targets a specific region of the microbial genome, the 16S ribosomal RNA gene.
Sample Presentation Sub-segment to Hold a Considerable Market Share
The sample presentation sub-segment holds a significant market share in the metagenomic sequencing market due to its crucial role in ensuring the quality and reliability of sequencing results. It encompasses sample preparation processes such as collection, preservation, extraction, and purification before sequencing. The growing recognition of sample quality's importance in metagenomic sequencing drives the demand for robust sample presentation protocols. High-quality samples are vital for accurate sequencing data, minimizing biases and artifacts. Researchers and clinicians prioritize these protocols to achieve optimal sequencing outcomes, emphasizing the sub-segment's importance in the market.
Regional Outlook
The globalmetagenomic sequencingmarket is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Asia-Pacific to Exhibit the Highest CAGR
The Asia-Pacific region emerges as the fastest-growing market due to a surge in research endeavours across various sectors, notably in microbiome studies, environmental monitoring, agriculture, and healthcare. Academic institutions, research organizations, and biotechnology firms in countries like China, Japan, South Korea, and India are actively involved in advancing metagenomic sequencing research and fostering market expansion. Additionally, rising healthcare expenditure, driven by economic growth and urbanization, fuels the adoption of advanced sequencing technologies for clinical diagnostics, drug discovery, and personalized medicine, further boosting demand for metagenomic sequencing solutions.
Supportive government initiatives and funding programs, such as China's Precision Medicine Initiative and India's National Biotechnology Development Strategy, further catalyze market growth by promoting genomic research and personalized medicine. For instance, in December 2023, Novogeneformalised a cooperation agreement with MGI, announcing the introduction of MGI’s DNBSEQ-T7 sequencing platform, marking a significant enhancement in its range of high-throughput sequencing services to meet the increasingly diverse needs of customers globally.
Global Metagenomic Sequencing Market Growth by Region 2024-2031
North America Holds Major Market Share
Among all the regions, North America holds a significant share due toadvanced healthcare infrastructure, characterized by top-tier research institutions and biotechnology companies, fosters extensive research and development in metagenomic sequencing. The region's substantial investment in R&D, particularly in microbiome research, drives technological advancements and innovation in sequencing solutions. Additionally, the presence of major players like Illumina and Thermo Fisher Scientific contributes to North America's dominance by ensuring access to cutting-edge sequencing technologies. For instance, in September 2022, Illumina, Inc., a US-based company, introduced the NovaSeq X series production-scale sequencers, boasting a capability of generating over 20,000 whole genomes annually, marking a significant advancement with 2.5 times the throughput compared to previous Illumina sequencers.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global metagenomic sequencing market includeF. Hoffmann-La Roche Ltd., AstraZeneca, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Eurofins Scientific and others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May2023, Ginkgo Bioworks, Inc., a leader in cell programming and biosecurity, partnered with Boehringer Ingelheim to leverage Ginkgo's metagenomic sequence database. This collaboration aims to expedite the identification of structurally novel bioactive molecules, potentially leading to the discovery of transformative treatments. Ginkgo stands to receive upfront research fees and success-based payments totalling up to $406 million for a predetermined number of projects under the terms of the cooperation.
The Report Covers
- Market value data analysis of 2023and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global metagenomic sequencing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. F. Hoffmann-La Roche Ltd.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. AstraZeneca Plc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Thermo Fisher Scientific Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Metagenomic Sequencing Market by Application
4.1.1. Drug Discovery
4.1.2. Clinical Diagnostic
4.1.3. Soil Microbiome
4.1.4. Industrial Applications
4.1.5. Ecological and Environmental
4.1.6. Veterinary
4.2. Global Metagenomic Sequencing Market by Product & Service
4.2.1. Reagents and Consumables
4.2.2. Instruments
4.2.3. Sequencing Services
4.2.4. Analysis and Data Interpretation Solutions
4.3. Global Metagenomic Sequencing Market by Technology
4.3.1. 16s Rna Sequencing
4.3.2. Shotgun Metagenomic Sequencing
4.3.3. Whole-Genome Sequencing and De Novo Assembly
4.3.4. Metatranscriptomics
4.4. Global Metagenomic Sequencing Market by Workflow
4.4.1. Sample Preparation
4.4.2. Sequencing
4.4.3. Data Processing and Analysis
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 10x Genomics, Inc.
6.2. Agilent Technologies, Inc.
6.3. Arc Bio, LLC
6.4. Azenta US, Inc.
6.5. BaseClear BV
6.6. BGI Genomics Co., Ltd. (BGI)
6.7. Bio-Rad Laboratories, Inc. (Bio-Rad's)
6.8. Computomics GmbH
6.9. CosmosID
6.10. DNASTAR
6.11. Eurofins Genomics
6.12. Eurofins Scientific
6.13. GenapSys, Inc.
6.14. Genewiz, Inc. (Azenta Life Sciences)
6.15. Illumina, Inc.
6.16. Intact Genomics Inc.
6.17. Integrated DNA Technologies
6.18. Macrogen Inc.
6.19. MedGenome Labs Ltd.
6.20. Microsynth AG
6.21. New England Biolabs, Inc.
6.22. Novogene
6.23. Oxford Nanopore Technologies
6.24. PacBio
6.25. Pattern AG
6.26. PerkinElmer, Inc.
6.27. Promega Corp.
6.28. Psomagen, Inc.
6.29. Qiagen
6.30. Takara Bio USA, Inc.’s
6.31. Tecan
6.32. Veritas Intercontinental
6.33. Zymo’s
1. GLOBAL METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
2. GLOBAL METAGENOMIC SEQUENCING IN DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
3. GLOBAL METAGENOMIC SEQUENCING IN CLINICAL DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
4. GLOBAL METAGENOMIC SEQUENCING IN SOIL MICROBIOME MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
5. GLOBAL METAGENOMIC SEQUENCING IN INDUSTRIAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
6. GLOBAL METAGENOMIC SEQUENCING IN ECOLOGICAL AND ENVIRONMENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
7. GLOBAL METAGENOMIC SEQUENCING IN VETERINARY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
8. GLOBAL METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICE, 2023-2031 ($ MILLION)
9. GLOBAL REAGENTS AND CONSUMABLES FOR METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
10. GLOBAL INSTRUMENTS FOR METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
11. GLOBAL SEQUENCING SERVICES FOR METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
12. GLOBAL ANALYSIS AND DATA INTERPRETATION SOLUTIONS FOR METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
13. GLOBAL METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
14. GLOBAL 16S RNA SEQUENCING IN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
15. GLOBAL SHOTGUN METAGENOMIC SEQUENCING IN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
16. GLOBAL WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY IN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
17. GLOBAL METATRANSCRIPTOMICS IN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
18. GLOBAL METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2023-2031 ($ MILLION)
19. GLOBAL SAMPLE PREPARATIONIN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
20. GLOBAL SEQUENCINGIN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
21. GLOBAL DATA PROCESSING AND ANALYSISIN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
22. GLOBAL METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
23. NORTH AMERICAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
24. NORTH AMERICAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
25. NORTH AMERICAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICE, 2023-2031 ($ MILLION)
26. NORTH AMERICAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY,2023-2031 ($ MILLION)
27. NORTH AMERICAN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY WORKFLOW,2023-2031 ($ MILLION)
28. EUROPEAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
29. EUROPEAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
30. EUROPEAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICE, 2023-2031 ($ MILLION)
31. EUROPEAN METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
32. EUROPEAN METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2023-2031 ($ MILLION)
33. ASIA-PACIFIC METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
34. ASIA-PACIFICMETAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
35. ASIA-PACIFICMETAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICE, 2023-2031 ($ MILLION)
36. ASIA-PACIFICMETAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
37. ASIA-PACIFICMETAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2023-2031 ($ MILLION)
38. REST OF THE WORLD METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
39. REST OF THE WORLD METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
40. REST OF THE WORLD METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICE, 2023-2031 ($ MILLION)
41. REST OF THE WORLD METAGENOMIC SEQUENCINGMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
42. REST OF THE WORLD METAGENOMIC SEQUENCING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2023-2031 ($ MILLION)
1. GLOBAL METAGENOMIC SEQUENCINGMARKETSHARE BY APPLICATION, 2023 VS 2031 (%)
2. GLOBAL METAGENOMIC SEQUENCING IN DRUG DISCOVERY MARKETSHARE BY REGION, 2023 VS 2031 (%)
3. GLOBAL METAGENOMIC SEQUENCING IN CLINICAL DIAGNOSTIC MARKET SHARE BY REGION, 2023 VS 2031 (%)
4. GLOBAL GENOMIC SEQUENCING IN SOIL MICROBIOMEMETA MARKET SHARE BY REGION, 2023 VS 2031 (%)
5. GLOBAL METAGENOMIC SEQUENCING IN INDUSTRIAL APPLICATIONS MARKET SHARE BY REGION, 2023 VS 2031 (%)
6. GLOBAL METAGENOMIC SEQUENCING IN ECOLOGICAL AND ENVIRONMENTAL MARKET SHARE BY REGION, 2023 VS 2031 (%)
7. GLOBAL METAGENOMIC SEQUENCING IN VETERINARY APPLICATION MARKET SHARE BY REGION, 2023 VS 2031 (%)
8. GLOBAL METAGENOMIC SEQUENCING MARKET SHAREBY PRODUCT & SERVICE, 2023 VS 2031 (%)
9. GLOBAL REAGENTS AND CONSUMABLES FOR METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
10. GLOBAL INSTRUMENTS FOR METAGENOMIC SEQUENCINGMARKET SHARE BY REGION, 2023 VS 2031 (%)
11. GLOBAL SEQUENCING SERVICES FOR METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
12. GLOBAL ANALYSIS AND DATA INTERPRETATION SOLUTIONS FOR METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
13. GLOBAL METAGENOMIC SEQUENCINGMARKET SHAREBY TECHNOLOGY, 2023 VS 2031 (%)
14. GLOBAL 16S RNA SEQUENCING IN METAGENOMIC SEQUENCINGMARKET SHARE BY REGION, 2023 VS 2031 (%)
15. GLOBAL SHOTGUN METAGENOMIC SEQUENCING INMETAGENOMIC SEQUENCINGMARKET SHARE BY REGION, 2023 VS 2031 (%)
16. GLOBAL WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY IN METAGENOMIC SEQUENCINGMARKET SHARE BY REGION, 2023 VS 2031 (%)
17. GLOBAL METATRANSCRIPTOMICSIN METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
18. GLOBAL METAGENOMIC SEQUENCING MARKET SHAREBY WORKFLOW, 2023 VS 2031 (%)
19. GLOBAL SAMPLE PRESENTATION IN METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
20. GLOBAL SEQUENCING IN METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
21. GLOBAL DATA PROCESSING AND ANALYSIS IN METAGENOMIC SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
22. GLOBAL METAGENOMIC SEQUENCINGMARKETSHARE BY REGION, 2023 VS 2031 (%)
23. US METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
24. CANADA METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
25. UK METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
26. FRANCE METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
27. GERMANY METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
28. ITALY METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
29. SPAIN METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
30. REST OF EUROPE METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
31. INDIA METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
32. CHINA METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
33. JAPAN METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
34. SOUTH KOREA METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
35. REST OF ASIA-PACIFIC METAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
36. LATIN AMERICAMETAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
37. MIDDLE EAST AND AFRICAMETAGENOMIC SEQUENCINGMARKET SIZE, 2023-2031 ($ MILLION)
